As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers
Chennai-based diabetologist V. Mohan prescribed a relatively new medication that has emerged as a “wonder drug” in the treatment of diabetes: Mounjaro. Developed by US pharma giant Eli Lilly, the weekly injection is approved for managing Type 2 diabetes, …